Background: the cornea exhibits viscoelastic properties, which give it the quality of hysteresis. Corneal hysteresis is an important indicator of the biomechanical properties of the cornea. Aim: to compare the biomechanical properties of the cornea in patients having diabetes mellitus and age matched normal individuals as regards to corneal hysteresis (CH), corneal resistance factor (CRF), Corneal compensated IOP (IOPcc) and Goldman-correlated IOP (IOPg). Patients and Methods: A total of 200 eyes of 100 patients were enrolled in our study. Patients were selected from Ophthalmology outpatient clinics in Minia Health Insurance Hospital -Ophthalmology department. The type of our study is a case-control one. Patients were divided into two equal groups: Group A: included 50 patients (100 eyes) of age matched normal individuals. Group B: included 50 patients (100 eyes) having type 2 diabetes mellitus. Results: mean CH in control group was 9.8±1.3 mm Hg in comparison to mean CH in diabetic group which was 11.9±1.4 mm Hg, which was statistically significantly higher in diabetic patients when compared to control group, (P value = 0.<001). Conclusion: the corneal biomechanics in diabetic group are significantly higher compared with those of the control group.
Introduction
Biomechanics of the cornea affect its functional responses and greatly impact vision. The physical composition of the cornea gives it a viscoelastic property which means that it exhibits elements of both elasticity and viscosity (1, 2) . Elasticity refers to the ability of a substance to deform reversibly under stress. Viscous materials, on the other hand, flow when an external shear force is applied and do not regain their original shape when the force is removed.
Viscoelastic materials exhibit characteristics of both viscosity and elasticity, resulting in energy dissipation when stress is applied. The energy lost in this dissipation process is called hysteresis (CH) (3) . The Ocular Response Analyzer (ORA) (Reichert Inc., Depew, New York), described by Luce (4) , is the only commercially available medical device capable of measuring corneal biomechanics. In vivo Studies have shown that CH is altered in various disease states. Measurement of CH also provides a more complete characterization of the contribution of corneal resistance to intraocular pressure (IOP) measurements than central corneal thickness (CCT) (5) . The ORA uses a puff of air to deflect the cornea while an infrared beam tracks changes in the shape of the anterior cornea during inward and outward deviation. Analysis of the parameters produced by the infrared waveform signal allows the calculation of several useful values. Corneal hysteresis (CH) is calculated as the difference in air pressures between force-in applanation (P1) and force-out applanation (P2), or (P1 -P2). However, corneal hysteresis values can be produced by various combinations of corneal thickness, rigidity, intraocular pressure, and hydration. Corneal resistance factor is another measurement provided by ORA (4) . Diabetes leads to complications in almost all ocular structures, diabetes significantly impacts the morphological, metabolic, physiological and clinical properties of the cornea (6) .
Aim of the Work:
To compare the biomechanical properties of the cornea in patients having diabetes mellitus and age matched normal individuals as regards to corneal hysteresis (CH), corneal resistance factor (CRF), Corneal compensated IOP (IOPcc) and Goldman-correlated IOP (IOPg).
Patients and Methods
A total of 200 eyes of 100 patients were enrolled in our study. 1-Fasting blood glucose (FBG).
2-Random blood glucose (RBG). 3-Glycated hemoglobin (Hb A1C). Ethical issues:
The hospital Ethics Committee approved the study.
Consent Process:
The population sample under study was instructed about research protocol and informed consent is granted from each participant before randomization.
Data analysis:
The collected data of normal and diabetic patients were tabulated in spreadsheets using Microsoft Office Excel 2007 (Microsoft Corporation, USA). The coded data were arranged for use in SPSS Statistical Computer Package (SPSS 2011, version 20, IBM Corporation, USA). The first step in statistical analysis was to conduct descriptive statistics on the file containing the collected data of the 100 patients. Descriptive data were summarized and presented herein for numerical data as the mean ± Standard deviation (SD).
Results
The ORA measurements:
1. Corneal hysteresis (CH): The CH of the study groups ranged from 6.9 to 15.5 mmHg with an average of 11.7±1.8 mmHg for the control group (group A) while It ranged from 9.6 to 17.7 mm Hg, with an average 11.9±1.4 mm Hg for the diabetic group (group B). The difference between the two groups was statistically highly significant (p-value = <0.001). 
<0.001
A correlation was done between the CH and the average of duration of diabetes for the diabetic group (group B). The correlation was found to be a weak positive linear correlation (r value = 0.273) (p value = 0.089). We also have correlated CH to the average level of HBA1c in the control group and it showed no correlation (r value = 0.005). 
Corneal resistance factor (CRF):
The CRF of the study groups ranged from 6.6 to 14 mm Hg, with an average of 9.41±1.5 mmHg for control group (group A) and ranged from 8.9 to 16.4 mmHg, with an average of 12.4±1.7 mm Hg for the diabetic group (group B). The difference between the two groups was statistically highly significant (p-value = 0.001). 
0.001
When we correlated CRF to the average duration of diabetes mellitus in the diabetic group (group B), the correlation was found to be a weak positive linear one (r value=0.237) (p value=0.141). When we did correlation between CRF and HBA1c in diabetic group (group B), it was found to be a moderate positive linear correlation, (r value=0.353) (p value= 0.025). 
Discussion
In our study, mean CH in control group (group A) was 9.8±1.3 mm Hg in comparison to mean CH in diabetic group (group B) which was 11.9±1.4 mm Hg, which was statistically significantly higher in diabetic patients when compared to control group, (P value = 0.<001).
Our results could be explained by increased glucose in diabetes that acts as a collagen crosslinking agent with the help of advanced glycation end products (AGEs). AGEs accumulate in collagen proteins, resulting in the formation of covalent cross-linking bonds and gradual corneal stiffening.
Kotecha et al.
(7) mentioned in their results that CH is slightly higher in diabetic eyes with P value = 0.21.
On the contrary, Sahin et al. (8) reported that mean CH in control group was 10.41 ±1.66 mm Hg in comparison to mean CH in diabetic group which was 9.51 ± 1.82 mm Hg. They also reported that mean CH was significantly lower in diabetic patients when compared to the control group, (P value = 0.0001). They explained the decrease in CH by an alteration in the collagenous components due to collagen cross-linking suggesting that the dampening effects of the cornea decrease due to diabetes and were induced to increase during the cross-linking of collagen fibrils.
Meanwhile, Goldich et al. (9) disagreed with our results as they noted that there was no statistically significant difference between the control and diabetic groups regarding CH values. They didn't note any explanations.
Scheler et al.
(10) also disagreed with our results as he showed that there were no differences detected between healthy controls and patients with well-controlled diabetes as regard to CH.
In present study, the mean CRF value of control group (group A) was 9.41±1.5 mm Hg in comparison to 12.4±1.7 mm Hg in diabetic group (group B) and the difference between both groups was significantly higher in diabetic patients, (P value= 0.001).
Cankaya et al.
(11) also showed similar results to ours as they reported that mean CRF in control group was 10.56 ± 0.5 mm Hg in comparison to 11.58 ± 0.6 mm Hg in diabetic group. the difference between control and diabetic groups was statistically significantly higher (P value <0.01) but they didn't explain this finding.
Conclusion
the corneal biomechanics in diabetic group are significantly higher compared with those of the control group as the mean CH is 9.8±1.3mmHg in the control group (group A) and is 11.9±1.4 mmHg in the diabetic group (group B). The difference in CH between the two groups is statistically highly significant, (p value = <0.100). Meanwhile the mean CRF is9.41±1.5 mmHg in the control group (group A) and is12.4±1.7mmHg in the diabetic group (group B) and the difference in CRF between the two groups is statistically highly significant, (p value = 0.001). In the control group, there is no correlation between CH and the average level of HBA1c, (r value=0.005) (p value = 0.974). However, there is a weak positive linear correlation between CH and the average level of HBA1C in the diabetic patients, (r value=0.129) (p value=0.427). There is a very weak negative linear correlation between CRF and the average level of HBA1c in the control group, (r value= -0.092) (p value= 0.570). However, the correlation between it and HBA1c in diabetic group is a moderate positive linear correlation, (r value=0.353) (p value=0.141).
